Last reviewed · How we verify

NCT03784807: Diafilm

New Strategies for Biofilm Related Infections

Status unknown Last updated 24 December 2018
What this trial tests

trial testing synovial calprotectin, confocal laser microscopy in Prosthetic Joint Infection in 99 participants. Status unknown.

Timeline
2 November 2018
Primary endpoint
30 September 2020
30 November 2020

Quick facts

Lead sponsorI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment99
Start date2 November 2018
Primary completion30 September 2020
Estimated completion30 November 2020
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio — full company profile →

Who can join

18 and older, any sex, with Prosthetic Joint Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to develop new assays for synovial fluid analysis able to improve diagnosis of prosthetic joint infections. In particular, use of synovial calprotectin as marker of infection, confocal laser scanning microscopy (CLSM) analysis and methods to assess antimicrobial susceptibility will be evaluated in synovial fluids collected from patients with septic and aseptic failure of the prosthetic implant.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Prosthetic Joint Infection

Currently open trials in the same condition.

Other I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03784807.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing